Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Correction to: The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up

Correction to: European Journal of Nuclear Medicine and Molecular Imaging

https://doi.org/10.1007/s00259-019-04583-2

The author name Bernhard Nilica was inadvertently interchanged in the original version of this article.

The original article has been corrected.

Author information

Correspondence to Irene Virgolini.

Additional information

This article is part of the Topical Collection on Erratum.

The online version of the original article can be found at https://doi.org/10.1007/s00259-019-04583-2

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Maffey-Steffan, J., Scarpa, L., Svirydenka, A. et al. Correction to: The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up. Eur J Nucl Med Mol Imaging 47, 740 (2020). https://doi.org/10.1007/s00259-019-04660-6

Download citation